Back
Regeneron Pharmaceuticals Stock Price Chart
Buy
66
REGN
Regeneron Pharmaceuticals
Last Price:
994.68
Seasonality Move:
8.36%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Regeneron Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 977.39 | Buy |
20-day SMA: | 943.58 | Buy |
50-day SMA: | 943.17 | Buy |
200-day SMA: | 881.75 | Buy |
8-day EMA: | 974.35 | Buy |
20-day EMA: | 955.84 | Buy |
50-day EMA: | 943.98 | Buy |
200-day EMA: | 887.86 | Buy |
Regeneron Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 15.36 | Buy |
Relative Strength Index (14 RSI): | 65.45 | Buy |
Chaikin Money Flow: | 265052 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (896.54 - 972.08) | Buy |
Bollinger Bands (100): | (913.29 - 972.57) | Buy |
Regeneron Pharmaceuticals Technical Analysis
May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Regeneron Pharmaceuticals Stock
Is Regeneron Pharmaceuticals Stock a Buy?
- Regeneron Pharmaceuticals share price is 987.27 while REGN 8-day simple moving average is 977.39, which is a Buy signal.
- The stock price of REGN is 987.27 while Regeneron Pharmaceuticals 20-day SMA is 943.58, which makes it a Buy.
- Regeneron Pharmaceuticals 50-day simple moving average is 943.17 while REGN share price is 987.27, making it a Buy technically.
- REGN stock price is 987.27 and Regeneron Pharmaceuticals 200-day simple moving average is 881.75, creating a Buy signal.
REGN Technical Analysis vs Fundamental Analysis
Buy
66
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy or a Sell?
-
Regeneron Pharmaceuticals stock is rated a Buy
The current Regeneron Pharmaceuticals [REGN] share price is $987.27. The Score for REGN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
Regeneron Pharmaceuticals Stock Info
Market Cap:
108.78B
Price in USD:
987.27
Share Volume:
310.82K
Regeneron Pharmaceuticals 52-Week Range
52-Week High:
998.33
52-Week Low:
684.81
Buy
66
Regeneron Pharmaceuticals (REGN)
is a Buy
Regeneron Pharmaceuticals Share Price Forecast
-
What is the Regeneron Pharmaceuticals stock price today?
The Regeneron Pharmaceuticals stock price is 987.27 USD today. -
Will REGN stock go up or go down?
Regeneron Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Regeneron Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regeneron Pharmaceuticals is not overvalued.
Is Regeneron Pharmaceuticals Stock a Buy?
- Regeneron Pharmaceuticals share price is 987.27 while REGN 8-day exponential moving average is 974.35, which is a Buy signal.
- The stock price of REGN is 987.27 while Regeneron Pharmaceuticals 20-day EMA is 955.84, which makes it a Buy.
- Regeneron Pharmaceuticals 50-day exponential moving average is 943.98 while REGN share price is 987.27, making it a Buy technically.
- REGN stock price is 987.27 and Regeneron Pharmaceuticals 200-day simple moving average is 887.86, creating a Buy signal.
Fundamental Analysis of Regeneron Pharmaceuticals
Is Regeneron Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.30 per share, an increase this year of $1.57 per share, and an increase next year of $3.26 per share.
Technical Analysis of Regeneron Pharmaceuticals
Should I short Regeneron Pharmaceuticals stock?
- REGN Moving Average Covergence Divergence (MACD) indicator is 15.36, suggesting Regeneron Pharmaceuticals is a Buy
- Regeneron Pharmaceuticals Relative Strength Index (RSI) is 65.45, which suggest Regeneron Pharmaceuticals is overbought
- The Bollinger Bands (25) for Regeneron Pharmaceuticals is (896.54 - 972.08), which suggest Regeneron Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Regeneron Pharmaceuticals is (913.29 - 972.57), which suggest Regeneron Pharmaceuticals is a Buy
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.